Business Description
RBC Bioscience Corp
ISIN : TW0006848005
Compare
Compare
Traded in other countries / regions
6848.Taiwan IPO Date
2021-10-25Description
RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 1.95 | |||||
| Debt-to-EBITDA | 9.61 | |||||
| Interest Coverage | 2.95 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 0.75 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -34.8 | |||||
| 3-Year EBITDA Growth Rate | -43.7 | |||||
| 3-Year EPS without NRI Growth Rate | -65.2 | |||||
| 3-Year FCF Growth Rate | -58.5 | |||||
| 3-Year Book Growth Rate | 8.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.69 | |||||
| 9-Day RSI | 28.33 | |||||
| 14-Day RSI | 34.9 | |||||
| 6-1 Month Momentum % | 25.16 | |||||
| 12-1 Month Momentum % | 22.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.33 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.62 | |||||
| Days Inventory | 150.24 | |||||
| Days Sales Outstanding | 52.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.26 | |||||
| Dividend Payout Ratio | 0.83 | |||||
| Forward Dividend Yield % | 5.26 | |||||
| 5-Year Yield-on-Cost % | 5.26 | |||||
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | 9.41 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.4 | |||||
| Operating Margin % | 15.24 | |||||
| Net Margin % | 8.87 | |||||
| FCF Margin % | 19.26 | |||||
| ROE % | 7.14 | |||||
| ROA % | 2.26 | |||||
| ROIC % | 3.42 | |||||
| ROC (Joel Greenblatt) % | 5.41 | |||||
| ROCE % | 4.81 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.39 | |||||
| PE Ratio without NRI | 14.09 | |||||
| PS Ratio | 1.29 | |||||
| PB Ratio | 0.99 | |||||
| Price-to-Tangible-Book | 1 | |||||
| Price-to-Free-Cash-Flow | 6.61 | |||||
| Price-to-Operating-Cash-Flow | 5.51 | |||||
| EV-to-EBIT | 20.75 | |||||
| EV-to-EBITDA | 12.96 | |||||
| EV-to-Revenue | 3.38 | |||||
| EV-to-FCF | 17.68 | |||||
| Price-to-Graham-Number | 0.79 | |||||
| Earnings Yield (Greenblatt) % | 4.82 | |||||
| FCF Yield % | 15.22 | |||||
| Forward Rate of Return (Yacktman) % | -36.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RBC Bioscience Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 194.615 | ||
| EPS (TTM) (NT$) | 1.32 | ||
| Beta | 0.24 | ||
| Volatility % | 21.4 | ||
| 14-Day RSI | 34.9 | ||
| 14-Day ATR (NT$) | 0.397398 | ||
| 20-Day SMA (NT$) | 19.9725 | ||
| 12-1 Month Momentum % | 22.84 | ||
| 52-Week Range (NT$) | 14.7 - 24.6 | ||
| Shares Outstanding (Mil) | 12.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RBC Bioscience Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RBC Bioscience Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
RBC Bioscience Corp Frequently Asked Questions
What is RBC Bioscience Corp(ROCO:6848)'s stock price today?
The current price of ROCO:6848 is NT$19.00. The 52 week high of ROCO:6848 is NT$24.60 and 52 week low is NT$14.70.
When is next earnings date of RBC Bioscience Corp(ROCO:6848)?
The next earnings date of RBC Bioscience Corp(ROCO:6848) is .
Does RBC Bioscience Corp(ROCO:6848) pay dividends? If so, how much?
The Dividend Yield %  of RBC Bioscience Corp(ROCO:6848) is 5.26% (As of Today), Highest Dividend Payout Ratio of RBC Bioscience Corp(ROCO:6848) was 3.52. The lowest was 0.83. And the median was 2.89. The  Forward Dividend Yield % of RBC Bioscience Corp(ROCO:6848) is 5.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers